Baxter and ScinoPharm Taiwan strategic deal develop, manufacture and commercialize five injectable oncology drugs
Baxter International and ScinoPharm Taiwan, Ltd. have agreed for strategic partnership to develop, manufacture and commercialize five injectable drugs used in a... Read More
Baxter’s Acquisition of Claris Injectables Limited to Expand Portfolio of Essential Generic Injectable Medicines
About the deal: Baxter International Inc, a global leader in sterile medication production and delivery, today entered into a definitive agreement to... Read More
Claris Injectables receives five 483s from US FDA for plant in Ahmedabad
Posted on31 Aug 2016
Comments0
Claris Injectables Ltd (CIL), a wholly-owned subsidiary of the Ahmedabad-based Claris Lifesciences Ltd, has received five 483s from the US Food &... Read More
Claris Lifesciences confirms patent challenge for its generic version of PROPOFOL in USA
Posted on26 Dec 2014
Tagsclaris, claris lifesciences, propofol ANDA, propofol Paragraph IV certification, propofol patent challenge
Comments0
Claris Lifesciences has filed an Abbreviated New Drug Application (ANDA) for Propofol for Injection, 10 mg/ml with the US Food and Drug... Read More